Michael Palte, MD, PhD

Position title: Principal Clinical Scientist, Multiple Sclerosis Research Unit, Biogen

Phone: Advisor: Dr. Ronald Raines

Graduation: 05/2012
Research Interest: Illuminating chemical basis and biological purpose for protein structures and protein function

Michael Palte


  • Caes BR, Palte MJ, and Raines RT (2013). Organocatalytic conversion of cellulose into a platform chemical. Chemical Science. 4:196-199.
  • Palte MJ, Davis AKF, McGrath NA, Spiegel CA, and Raines RT (2012).Ribonucleotide 3′-phosphates as pro-moieties for an orally administered drug. ChemMedChem. 7:1361-1364. PMID: 22807330
  • Ellis GA, McGrath NA, Palte MJ, & Raines RT (2012). Ribonuclease-activated cancer prodrug. ACS Med. Chem. Lett. 3:268–272. PMCID: PMC3353771
  • Palte MJ and Raines RT (2012). Interaction of Nucleic Acids with the Glycocalyx. J Am Chem Soc. 134:6218–6223. PMCID: PMC3353769
  • Lukesh JC, Palte MJ, and Raines RT (2012). A potent, versatile disulfide-reducing agent from aspartic Acid. J Am Chem Soc. 134:4057-4059. PMCID: PMC3353773. As featured in Chemical & Engineering News: A Better Disulfide Reducing Agent. 2012 Feb 29.
  • Ellis GA,* Palte MJ,* and Raines RT (2012). Boronate-mediated biologic delivery. J Am Chem Soc. 134:3631-3634. PMCID: PMC3304437 (* denotes equal contribution). As featured in Chemical & Engineering News: Drug Delivery Hooked On Sugar. 2012 Feb 15 and Nature, 484, 9 (2012): Community Choice Highlight, Proteins’ ticket into the cell.